In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
about
Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure.
P2860
In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In vivo development of daptomy ...... ly treated with glycopeptides.
@en
type
label
In vivo development of daptomy ...... ly treated with glycopeptides.
@en
prefLabel
In vivo development of daptomy ...... ly treated with glycopeptides.
@en
P2093
P2860
P1476
In vivo development of daptomy ...... sly treated with glycopeptides
@en
P2093
P2860
P2888
P304
P356
10.1007/S10096-016-2581-4
P577
2016-01-27T00:00:00Z
P5875
P6179
1012172456